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Candida albicans is a dimorphic fungus responsible
for chronic mucocutaneous and systemic infec-
tions. Mucocutaneous immunity to C. albicans re-
quires T helper 17 (Th17) cell differentiation that is
thought to depend on recognition of filamentous
C. albicans. Systemic immunity is considered T cell
independent. Using a murine skin infection model,
we compared T helper cell responses to yeast and
filamentous C. albicans. We found that only yeast
induced Th17 cell responses through a mechanism
that required Dectin-1-mediated expression of inter-
leukin-6 (IL-6) by Langerhans cells. Filamentous
forms induced Th1 without Th17 cell responses due
to the absence of Dectin-1 ligation. Notably, Th17
cell responses provided protection against cuta-
neous infection while Th1 cell responses pro-
vided protection against systemic infection. Thus,
C. albicans morphology drives distinct T helper cell
responses that provide tissue-specific protection.
These findings provide insight into compartmentali-
zation of Th cell responses and C. albicans patho-
genesis and have critical implications for vaccine
strategies.
INTRODUCTION
Candida albicans is a human commensal and a common
mucosal and systemic pathogen in the setting of immunosup-
pression. Chronic mucocutaneous candidiasis (CMC) occurs in
the absence of innate sources of interleukin-17 (IL-17) and
IL-22 as well as in the setting of ineffective T helper 17 (Th17)
cell-type immunity in both mice and humans (e.g., HIV/AIDS or
hyper IgE syndrome) (Herna´ndez-Santos et al., 2013; McDonald,
2012; Murray et al., 1985). CMC is also associated with356 Immunity 42, 356–366, February 17, 2015 ª2015 Elsevier Inc.mutations in the fungal recognition C-type lectin receptor Dec-
tin-1 or its downstream signaling molecules (Ferwerda et al.,
2009; Glocker et al., 2009). In contrast, systemic candidiasis
predominantly occurs in the clinical setting of neutropenia and
in mice with innate immune defects (e.g., Il6/ mice) resulting
in ineffective neutrophil activation but does not occur in the
absence of Th17-cell-associated or adaptive immunity (Ba¨r
et al., 2014; Horn et al., 2009; van de Veerdonk et al., 2010;
van Enckevort et al., 1999).
C. albicans is dimorphic and grows as yeast at 30C and as a
filamentous or hyphal form at 37C. On the stratum corneum of
the skin, C. albicans exists as budding yeasts. Pathogenic
C. albicans in the dermis and systemic organs exists predomi-
nantly as pseudo-hyphae (Gow et al., 2012). C. albicansmutants
that are unable to form filaments fail to establish robust infec-
tions, suggesting that the yeast-to-hyphal transition is required
for virulence (Lo et al., 1997). This transition has also been sug-
gested to be required for the development of anti-Candida
Th17 cell responses, thereby allowing for discrimination between
commensal and invasive C. albicans (Gow et al., 2012). In vitro,
C. albicans pseudo-hyphae induce Dectin-1-mediated Th17
cell differentiation (Cheng et al., 2011). C. albicans pseudo-
hyphae, however, have also been reported to promote Th1 and
Th2 cell differentiation in vitro (d’Ostiani et al., 2000; van der
Graaf et al., 2005). Importantly, T helper (Th) cell responses
in vivo to yeast and filamentous forms of C. albicans and the
ability of these adaptive responses to provide protection remain
unclear.
In the skin, there are at least three well-defined subsets of den-
dritic cells (DCs): epidermal Langerhans cells (LCs), CD103+
dermal DC (dDCs), and CD11b+ dDCs (Kaplan, 2010). These
DC subsets migrate from the skin into regional lymph nodes dur-
ing infection where they present antigen to naive T cells and
secrete cytokines that determine Th cell differentiation (Reis e
Sousa, 2004). During epicutaneous infection with C. albicans,
CD103+ dDCs generate IL-12 and are required for differentiation
of Th1 cells (Igya´rto´ et al., 2011). LCs are required for Th17 cell
differentiation and express high amounts of Th17-cell-inducing
cytokines IL-1b, transforming growth factor-b (TGF-b), and
IL-6. The importance of individual cytokines in generating Th17
cells in vivo is controversial and varies by tissue. It has been
demonstrated that IL-1b and IL-6 are both necessary for Th17
cell differentiation in peripheral tissues including skin (Hu et al.,
2011). Th17 cell induction in the spleen is independent of IL-6
but not IL-1b. In the intestines, several studies have confirmed
an IL-1b dependence for Th17 cell development although the
requirement for IL-6 remains controversial (Hu et al., 2011;
Persson et al., 2013; Shaw et al., 2012).
CD11b+ dDCs make up the majority of the skin migratory DCs
and drive Th2 cell differentiation in the setting of dermal papain
injection or parasitic infection (Gao et al., 2013; Kumamoto
et al., 2013). In the setting ofC. albicans infection, this DC subset
generates high amounts of IL-1b and to a lesser extent IL-6 and
IL-12 (Igya´rto´ et al., 2011). Their ability, however, to promote Th
cell differentiation other than Th2 cell differentiation remains
unexplored (Kumamoto et al., 2013). Based on the functional
differences between skin DC subsets and the transition of
C. albicans from yeast to filamentous forms during epidermal
invasion, we hypothesized that DC subsets and C. albicans
morphology together determine Th cell differentiation.
Because of the requirement for immunosuppression to estab-
lish robust and consistent oropharyngeal C. albicans infection,
we have focused on epicutaneous C. albicans infection. We
found that infection with C. albicans yeast but not pseudo-
hyphae was capable of inducing Th17 cell responses through a
mechanism that required interaction with LCs, engagement of
Dectin-1, and LC-derived IL-6. C. albicans in the dermis failed
to induce Th17 cell differentiation despite the expression of Dec-
tin-1 on CD11b+ dDCs due to the absence of Dectin-1 ligation by
pseudo-hyphae that are the dominant morphology at that site.
Finally, we demonstrated that Th17 but not Th1 cells were pro-
tective against secondary cutaneous infections whereas Th1
but not Th17 cells were protective against secondary systemic
infections. Thus, C. albicans morphology and skin DC subsets
drive distinct Th cell responses that provide protection from
either cutaneous or systemic infections.
RESULTS
Distinct T Helper Cell Responses Mediated by
C. albicans Morphology
We have previously generated recombinant C. albicans derived
from the standard SC5314 strain that expresses the peptides
2W1S and Ea, under the ubiquitous Eno1 promoter (Eno1-Ag).
Using a TEa CD4+ T cell adoptive transfer system, we showed
that mice that express diphtheria toxin fragment A (DTA) under
a human Langerin (huLangerin) promoter with a constitutive
absence of LCs (henceforth referred to as LC) failed to generate
antigen-specific Th17 cells (Igya´rto´ et al., 2011). To exclude the
possibility that this phenotype resulted from a chronic absence
of LCs, we repeated these experiments with mice that express
the diphtheria toxin receptor (DTR) within huLangerin (referred
to has huLangerin-DTR mice) that allow for inducible ablation
of LCs (Bobr et al., 2010). As expected, ablation of LCs just prior
to Eno1-Ag infection also prevented efficient Th17 cell differen-
tiation (Figure S1A). We next examined the responses of endog-
enous antigen-specific CD4+ T cells to C. albicans by using
I-Ab:p2W1S tetramer staining 8 days after infection. Expansionof p2W1S-specific cells was equivalent in control and LC-
deficient mice (Figure 1A). Expansion of cells producing IL-17A
but not interferon-g (IFN-g), however, was significantly reduced
in LC-deficient mice (Figure 1B). Thus, consistent with our earlier
observations using adoptive transfer of T cell receptor (TCR)
transgenic T cells specific for Ea (TEa), LCs are required for
efficient differentiation of endogenous naive CD4+ T cells into
Th17 cells.
To determine whether recognition by LCs of yeast or fila-
mentous forms of C. albicans affects Th cell differentiation, we
selectively targeted antigen to LCs by i.p. injection of 1.0 mg
anti-huLangerin mAb-Ea conjugates (2G3-Ea) in human Lan-
gerin transgenic mice (huLangerin) (Figure S1B; Flamar et al.,
2012; Igya´rto´ et al., 2011; Kaplan et al., 2012). HuLangerin is
expressed exclusively by LCs in these mice, resulting in efficient
and LC-selective acquisition of 2G3-Ea. As a source of adjuvant,
we epicutaneously infected 2G3-Ea-targeted huLangerin mice
with wild-type SC5314 as well as cph/cph and tup1/tup1 mu-
tants derived from SC5314 that are locked into yeast or hyphal
forms, respectively (Braun and Johnson, 1997; Liu et al., 1994).
Expansion of adoptively transferred TEa cells was equivalent in
mice infected with all three strains (Figure 1C). Notably, Th17
cell differentiation was intact in the mice infected with the
yeast-locked cph1 mutant but was absent in those infected
with the filament-locked tup1 mutant, suggesting that LC-
mediated Th17 cell differentiation requires the presence of
C. albicans yeast forms (Figure 1D).
To determine the effect of C. albicansmorphology under con-
ditions inwhich antigenpresentation is not limited to LCs,wenext
generated recombinant C. albicans in which expression of a
fusion protein of GFP with the antigens Ea and 2W1S was driven
by the promoter for the pseudo-hyphae-specific gene Hwp1
(Hwp1-Ag) (Staab et al., 1999). Unlike Eno1-Ag where GFP
expression was present in all C. albicansmorphologies, expres-
sion of GFP by Hwp1-Ag was absent in yeast and observed only
for filamentous forms (Figures 1E and S2A–S2E). Both Eno1-Ag
andHwp1-Ag strains demonstrated similar virulence in vivo after
epicutaneous or intravenous infection (Figure S2F and S2G). Epi-
cutaneous infection of WT mice with Eno1-Ag and Hwp1-Ag
induced similar antigen-specific CD4+ T cells expansion and
Th1 cell differentiation (Figure 1F). Notably, mice infected with
Hwp1-Ag failed to efficiently induce Th17-cell-associated
responses (Figure 1G). Thus, LCs and C. albicans yeast but not
pseudo-hyphae are required for optimal Th17 cell differentiation.
Th17 Cell Differentiation Requires LC-Derived IL-6
In vitro, Th17 cell differentiation of naive cells requires combina-
tions of IL-1b, IL-6, IL-23, and TGF-b (Chung et al., 2009; Ivanov
et al., 2006; Zu´n˜iga et al., 2013). The requirement for IL-1b and
IL-6 in vivo differs based on the site of immunization (Hu et al.,
2011; Shaw et al., 2012). To determine which cytokines are
responsible for LC-mediated Th17 cell induction, we first
compared responses in IL-1b- and IL-6-deficientmice.We found
that both IL-1b and IL-6 deficiency resulted in diminished Th17
cell responses (Figures 2A and 2B). Notably, Th17 cells were
entirely absent in Il6/ mice and was associated with a recip-
rocal increase in Th1 cells (Figures 2B and 2C).
Because LCs express of IL-1b, TGF-b, and IL-6 during
C. albicans infection (Igya´rto´ et al., 2011), we next sought toImmunity 42, 356–366, February 17, 2015 ª2015 Elsevier Inc. 357
Figure 1. Candida albicans Yeast Drives Th17 Cell Differentiation In Vivo
(A) The number of 2W1S-specific CD4+ T cells in six skin draining lymph nodes (axillary, brachial, inguinal) and spleen 8 days aftermock (Neg) or skin infectionwith
Eno1-Ag in wild-type (WT) or LC-deficient (LC) mice is shown.
(B) Percentage of PMA-and-ionomycin-stimulated 2W1S-specific cells in WT (white) or LC (black) mice expressing the indicated cytokines.
(C) Antigen was targeted to huLangerin transgenic mice by i.p injection of 1.0 mg 2G3-Ea. Adjuvant was provided by skin infection with wild-type, cph1/cph1, or
tup1/tup1 strains of C. albicans. TEa numbers were assessed in the skin draining lymph nodes of mice 4 days after infection. Neg refers to unimmunized mice.
(D) The expression of IFN-g and IL-17A in PMA-and-ionomycin-stimulated Ea-specific CD4+ TEa cells from (C) is shown.
(E) GFP expression in Eno1-Ag or Hwp1-Ag C. albicans under yeast or filamentous growth conditions was determined by immunofluorescence.
(F and G) TEa expansion (F) and cytokine production (G) 4 days after infection of WT mice with Eno1-Ag (white) or Hwp1-Ag (black) or naive (Neg).
Each symbol represents data from an individual animal. Scales represents mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative of two to three
independent experiments. See also Figures S1 and S2.determine which cytokines were required for Th17 cell differen-
tiation. To generate LC-specific ablation of TGF-b1, we used
huLangerin-creER-T2 Tgfb1f/f mice that efficiently and selectively
excise TGF-b1 in LCs after administration of tamoxifen (Bobr
et al., 2012). We have previously reported that ablation of TGF-
b1 in LCs results in a gradual spontaneous migration of LCs
out of the epidermis over the course of weeks. To avoid this
potential confounding factor, we infected mice on day 5 after
tamoxifen administration, a time point when TGF-b has been effi-
ciently excised but LCs have not begun to migrate in large
numbers. As controls, we also infected tamoxifen-treated
huLangerin-creER-T2 YFP and huLangerin-creER-T2 Tgfbr2f/f
mice, which maintain TGF-b expression but also have increased358 Immunity 42, 356–366, February 17, 2015 ª2015 Elsevier Inc.homeostatic migration (Bobr et al., 2012). Antigen-specific T cell
expansion and Th cell phenotype differentiation was equivalent
in all three strains, demonstrating that LC-derived TGF-b is not
required for Th17 cell differentiation (Figures 3A and 3B).
To generate LC-specific ablation of IL-1b and IL-6, we gener-
ated WT/Il1b/ and WT/Il6/ bone marrow chimeras. LCs
are the only radio-resistant antigen-presenting cells (APCs) in the
skin and remained of cytokine-deficient host origin while the
hematopoietic system achieved 90%–96% chimerism (Figures
S3A–S3C). Infected WT/Il1b/ chimeras developed cell pro-
liferation and Th cell differentiation similar to control WT/WT
mice, indicating that LC-derived IL-1b is not required for Th17
cell induction (Figures 3C and 3D). In contrast, Th17 cell
Figure 2. IL-1b and IL-6 Are Required for
Th17 Cell Differentiation during C. albicans
Skin Infection
(A) Expansion of TEa cells isolated from skin
draining lymph nodes 4 days after skin infection
of the indicated mouse strains with Eno1-Ag
C. albicans. Each symbol represents results from
an individual animal.
(B and C) The percent of ex vivo PMA-and-
ionomycin-stimulated TEa cells in cutaneous lymph nodes that express IL-17A (B) or IFN-g (C) as determined intracellular flow cytometry is shown.
Neg refers to mock infected WT mice. Scales represents mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative of at least three independent
experiments.differentiation was reduced in WT/Il6/ chimeras, indicating
that LC-derived IL-6 is required for Th17 cells (Figures 3E and
3F). Moreover, Th17 cell differentiation was intact in Il6//
WT mice in which LCs were the only IL-6-sufficient hemato-
poietic cell type (Figure 3H). Thus, IL-6 derived from LCs is
necessary for Th17 cell induction during skin infection.
LC-Derived IL-6 Requires Dectin-1 Engagement
A subset of patients with chronic mucocutaneous candidiasis
(CMC) have mutations in the transcription factor STAT3, which
acts downstreamof the IL-6 receptor (McDonald, 2012). Patients
with Dectin-1 polymorphisms also suffer from CMC and have
decreased IL-6 production by their peripheral blood mononu-
clear cells (PBMCs) (Ferwerda et al., 2009). In addition, budding
yeast engages Dectin-1 whereas yeast but not pseudo-hyphae
trigger IL-6 secretion in human PBMCs (Armitage et al., 2011).
Because Th17 cell differentiation depends on LC-derived IL-6,
we next sought to determine whether Th17 cell differentiationFigure 3. LC-Derived IL-6, but Not TGF-b or IL-1b, Is Required for Th1
(A and B) huLangerin-creERT2 Tgfb1f/f mice were treated with tamoxifen to genera
C. albicans along with tamoxifen-treated huLangerin-creERT2 Tgfbr2f//f and YFP
shown.
(C and D) Expansion (C) and cytokine production (D) by TEa cells in Eno1-Ag-inf
shown.
(E–G) The expansion (E), expression of IL-17A by TEa cells (F), and percent of TEa
(black) mice is shown.
(H) Cytokine production by TEa cells in WT/WT (white) or Il6/ WT (black) mic
Scales represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Data are reprerequired engagement of Dectin-1 on LCs. We took advantage
of a clinical isolate, s20175.016, that has similar virulence as
SC5314 but its immune recognition is independent of Dectin-1
(Figure S4A and S4B; Marakalala et al., 2013). Antigen was
targeted to LCs in huLangerin mice using 2G3-Ea followed by
infection with SC5314 or s20175.016. As expected, CD4+
T cell expansion and Th1 cell differentiation were comparable
between the two experimental groups but Th17 cell differentia-
tion was reduced in mice infected with s20175.016 (Figures 4A
and 4B). Analysis of LCs isolated from the skin draining lymph
nodes 3 days after infection revealed a large reduction in IL-6
production in mice infected with s20175.016 compared with
SC5314 (Figures 4C and S5). Moreover, intradermal injection
of 1 mg recombinant IL-6 at the time of infection restored Th17
cell differentiation (Figure 4D). Finally, we directly explored the
necessity of Dectin-1 signaling by comparing the host response
to C. albicans infection in Dectin-1 deficient (Clec7a/) mice.
Whereas WT and Clec7a/ mice strains exhibited similar7 Cell Differentiation
te LC-specific ablation of TGF-b1. These mice were skin infected with Eno1-Ag
controls. Expansion of TEa at day 4 (A) along with cytokine expression (B) is
ected WT/WT (white) or WT/Il1b/ (black) bone marrow chimeric mice is
cells (G) producing the indicated cytokines in WT/WT (white) or WT/Il6/
e is shown. Neg refers to mock infected WT mice.
sentative of at least three independent experiments. See also Figure S3.
Immunity 42, 356–366, February 17, 2015 ª2015 Elsevier Inc. 359
Figure 4. Dectin-1 Engagement on LCs Leads to IL-6 Production and Th17 Cell Differentiation
Antigen was directed to LCs in huLangerin transgenic by i.p. injection of 1.0 mg 2G3-Ea followed by skin infection with SC5314 (white) or s20175.016 (black)
strains of C. albicans.
(A and B) TEa expansion (A) and cytokine production (B) by TEa cells is shown.
(C) LCs were isolated from the skin draining lymph nodes by flow cytometry sorting on day 3 after skin infection with vehicle (white), SC5314 (gray), or s20175.016
(black). Expression of the indicated cytokines was determined by qPCR and is shown normalized to uninfected mice.
(D) Antigenwas targeted to LCs (as in A) followed by infection with SC5314 or S20175.016. At the time of infection, PBS or 1.0 mg of rIL-6 was injected at the site of
infection. CSFE dilution of TEa cells as well as expression of IL-17A is shown.
(E) Expansion of TEa cells in the skin draining lymph nodes of WT and Dectin-1-deficient mice 4 days after infection with Eno1-Ag.
(F) CFSE dilution and expression of IL-17A in PMA-and-ionomycin-stimulated TEa cells isolated from WT and Dectin-1-deficient mice on day 4 after infection.
Neg refers to mock infected WT mice. Scales represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative of at least two independent
experiments. See also Figures S4 and S5.T cell expansion, Dectin-1-deficient host demonstrated dimin-
ished Th17 cell responses (Figures 4E and 4F). Thus Th17 cell
differentiation requires engagement of Dectin-1 on LCs that
results in increased expression of IL-6.
Absence of Dectin-1 Ligands Prevent Th17 Cell
Induction by Dermal DCs
To examine the function of dermal DC subsets in the induction of
Th17 cell responses, we first compared expression of Dectin-1
by each subset. Dectin-1 is expressed by LCs and CD11b+
dDCs but not by CD103+ dDCs (Figure 5A). The absence of
Dectin-1 on CD103+ dDCs is consistent with our previous obser-
vation that this DC subset was required for Th1 but not Th17 cell
induction (Igya´rto´ et al., 2011).
Because Th17 cell differentiation is reduced but not ablated in
the absence of LCs and because CD11b+ DCs in the lung are
required for Th17 cell responses during Aspergillus fumigatus
infection (Schlitzer et al., 2013), we hypothesized that CD11b+
dDCs could also contribute to Th17 cell during skin infection.
Macrophage galactose C-type lectin type 2 (Mgl2) is expressed
by most CD11b+ dDCs. Administration of diphtheria toxin (DT) to
the recently reported Mgl2-DTR mice results in ablation of
CD11b+ dDCs and LCs (Figures S6A–S6C; Kumamoto et al.,
2013). DT-treated Mgl2-DTRmice have reduced Th17 cell differ-
entiation that could result from deletion of either subset (Fig-
ure S6D). To selectively ablate CD11b+ dDCs, we generated
Mgl2-DTR/WT chimeric mice (Figure S6C). Notably, antigen-
specific T cell expansion and Th cell phenotype was unaltered360 Immunity 42, 356–366, February 17, 2015 ª2015 Elsevier Inc.in DT-treated Mgl2-DTR/WTmice infected with Eno1-Ag, indi-
cating that CD11b+ dDCs are not required for Th17 cell differen-
tiation (Figures 5B and 5C). To determine whether this DC subset
could be sufficient for Th17 cell induction, we generated LC 3
Batf3/ mice that have a genetic absence of both LCs and
CD103+ dDCs. Eno1-Ag infection of these mice in which
CD11b+ dDCs are the dominant skin-resident DC subset
demonstrated defective Th1 and Th17 cell differentiation (Fig-
ures 5D and 5E) that is consistent with the absence of Th17 cells
generated by LCs and Th1 cells induced by CD103+ dDCs. Thus,
CD11b+ dDCs are neither necessary nor sufficient for Th17 cell
generation during epicutaneous infection with C. albicans.
Despite the equivalent degree of T cells expansion in LC 3
Batf3/ mice, we considered the possibility that CD11b+
dDCs have limited access to antigen during an epicutaneous
infection. In wild-type mice, we compared epicutaneous with
dermal infection by using the same inoculum of Eno1-Ag.
Though T cell expansion and Th1 cell differentiation was similar,
Th17 cell differentiation was greatly reduced in response to intra-
dermal infection (Figures 6A and 6B). Induction of Th17 cell was
also absent in response to an i.v. systemic infection (Figures S7A
and S7B). Notably, addition of the Dectin-1 ligand, curdlan, with
the intradermal inoculation rescued the Th17 cell response, sug-
gesting that Dectin-1 ligation does not occur in the dermis during
C. albicans infection but that CD11b+ dDCs do have the capacity
to induce Th17 cells (Figure 6C). During epicutaneousC. albicans
infection, yeast are found on the epidermis and invasive filamen-
tous forms in the dermis (Figure 6D; Gow et al., 2012). To test
Figure 5. CD11b+ Dermal DCs Are Not Required for Th17 Cell Differentiation
(A) Surface expression of Dectin-1 by the indicated skin DC subset isolated from the skin under steady-state conditions is shown.
(B) Mgl2-DTR/WT chimeric mice were treated with vehicle (white circles) or diphtheria toxin (black circles) and skin infected with Eno1-Ag 1 day later. The
expansion of TEa cells isolated from skin draining lymph nodes 4 days after infection is shown. Neg represents mock infected WT mice (triangles).
(C) Expression of the indicated cytokines from PMA and ionomycin TEa cells in (B) is shown.
(D and E) Expansion (D) and cytokine production (E) by TEa cells in WT (white) or LC 3 Batf3/ (black) mice 4 days after infection with Eno1-Ag is shown.
Scales represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative of at least three independent experiments. See also Figure S6.whether hyphal forms of C. albicans are unable to induce Th17
cells due to the absence of Dectin-1 ligands, we infected mice
epicutaneously with Hwp1-Ag with the addition of exogenous
curdlan or vehicle (Figure 6E). The addition of Dectin-1 ligands
rescued the ability of antigen expressed by hyphal forms of
C. albicans to generate Th17 cell responses.
Compartmentalization of Th Cell Responses
The ability of C. albicans to induce Th17 cells in response to an
epidermal infection and Th1 cells in response to an invasive
infection raises the possibility that specific Th cell phenotypes
could provide protection at distinct anatomical sites. To test
this hypothesis, we epicutaneously infected WT, Il6/, and
Batf3/mice with Eno1-Ag. As expected, Il6/mice generated
a robust Th1 cell response in the absence of Th17 cells and
Batf3/ mice developed a strong Th17 cell response in the
absence of Th1 cells (Figure 7A). Separate cohorts of mice
were re-challenged by skin infection 9 days after spontaneous
clearance of the primary infection. The number of colony forming
units (CFUs) found in naive mice challenged with SC5314 was
similar in all three groups (open symbol) (Figure 7B). Notably,
though IL-6 is an innate cytokine important for resistance to sys-
temic C. albicans infection, naive Il6/ mice did not develop an
exaggerated cutaneous infection (van Enckevort et al., 1999).
Secondarily infected (closed symbols) WT mice had an approx-
imate 10-fold increase in fungal resistance. In contrast, Batf3/
mice had approximately 100-fold increase in pathogen resis-
tance and Il6/ mice showed no increased resistance to re-
infection compared to naive mice (Figure 7B). To test whether
this was a CD4+-T-cell-dependent process, we purified CD4+
T cells from Il6/ and Batf3/ mice infected 7 days earlier
and adoptively transferred them into naive hosts that were
then skin infected. Naive recipients of CD4+ T cells from Batf3/
but not Il6/micewere protected against a cutaneous infection.Thus, the Th17 cells that arise in response to a cutaneous
C. albicans infection provide protection against subsequent
skin challenges (Figure 7C).
In contrast, systemic challenge of previously skin-infected
mice by i.v. inoculation revealed protection in WT and Il6/
mice but not in Batf3/ mice (Figure 7D). Similarly, adoptive
transfer of CD4+ T cells from skin-infected Il6/ mice but not
Batf3/ mice into naive recipients conferred protection against
systemic candidiasis (Figure 7E). Thus, mice with expanded
numbers of Th17 cell effectors were more resistant to cutaneous
C. albicans challenge whereas mice with expanded numbers of
Th1 cells were more resistant to systemic challenge. We
conclude that Th cell effector cells appear to be functionally
compartmentalized, with Th17 cells providing skin protection
and Th1 cells providing systemic protection.
DISCUSSION
Herein we have demonstrated that the differentiation of Th17
cells in response to C. albicans skin infection occurs during
infection with C. albicans yeast but not pseudo-hyphae. Th17
cell induction required the engagement of Dectin-1 and subse-
quent expression of IL-6 by Langerhans cells. CD11b+ dDCs
expressed Dectin-1 but were neither necessary nor sufficient
for Th17 cell responses. The inability of C. albicans in the dermis
to induce Th17 cells resulted from a morphologic change from
yeast to pseudo-hyphae that occurred during invasion and could
be rescued by the addition of exogenous Dectin-1 ligand. Finally,
we found that Th17 cell expansion provided protection against
cutaneous but not systemic challenge whereas the Th1 cell
expansion provided protection against systemic but not cuta-
neous challenge.
The ability of C. albicans morphology to dictate immune
responses has been an area of considerable controversy. OurImmunity 42, 356–366, February 17, 2015 ª2015 Elsevier Inc. 361
Figure 6. Dermal Infection and C. albicans Pseudo-Hyphae Do Not Induce Th17 Cells without Exogenous Dectin-1 Ligands
(A and B)WTmice were infectedwith an equivalent inoculum of Eno1-AgC. albicans on the epidermis (white) or by intradermal injection (black). Expansion (A) and
cytokine production (B) by PMA-and-ionomycin-stimulated TEa cells isolated from skin draining lymph nodes is shown.
(C) As in (A), WT mice were infected epicutaneously or by dermal injection into which purified curdlan or vehicle has been added to the inoculum. CSFE dilution
and expression of IL-17A by PMA-and-ionomycin-stimulated TEa cells is shown.
(D) PAS stain of skin 2 days after C. albicans infection showing budding yeast (asterisk) restricted to the epidermis and numerous penetrating pseudo-hyphae in
the dermis (arrowhead) (scale bar represents 150 mM).
(E) The expression of IL-17A and IFN-g by PMA-and-ionomycin-stimulated TEa cells 4 days after epicutaneous infection of WTmice with Eno1-Ag orHwp1-Ag is
shown. Curdlan or vehicle alone was provided by dermal injection at the time of infection.
‘‘Neg’’ represents mock infectedWTmice. Scales represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative of at least three independent
experiments. See also Figure S7.data using mutants that are locked into yeast (chp1/cph1)
or pseudo-hyphae (tup1/tup1) as well as a recombinant
C. albicans strain in which model antigens are expressed exclu-
sively by pseudo-hyphae (Hwp1-Ag) demonstrate that, in vivo,
C. albicans yeast but not pseudo-hyphae induce Th17 cell differ-
entiation. This is consistent with the finding that the ligand for
Dectin-1 is largely accessible in the scars or patches of budding
yeasts (Cabib and Bowers, 1971; Gantner et al., 2005; Gow et al.,
2012). Using in vitro methods, others have found thatC. albicans
pseudo-hyphae can induce Dectin-1-mediated Th17 cell differ-
entiation through an IL-1b-dependent mechanism as well as
induce Th2 or Tr1 cell responses (Cheng et al., 2011; d’Ostiani
et al., 2000). These data can be reconciled by the differing avail-
ability in vitro versus in vivo of Dectin-1 ligands on morphologic
forms of C. albicans (Marakalala et al., 2013).
Differentiation of Th17 cells requires TGF-b as well as IL-1b
and/or IL-6 depending on the site of immunization (Hu et al.,
2011). Using total cytokine-deficient mice, we found that Th17
cell development during skin infection is dependent on both
IL-1b and IL-6. By generating mice with LC-selective defects of
TGF-b1, IL-1b, and IL-6, we found that LCs were a non-redun-
dant source of only IL-6. Though LC-derived IL-1b and TGF-b
were not required, there are many other cellular sources of these
cytokines that could either be the primary source during infection
or provide functionally sufficient quantities in the absence of
LCs. Notably, specific ablation of MyD88 in LCs resulted in
reduced expression of IL-6 and defective Th17 cell differentia-
tion during C. albicans infection, suggesting that IL-1b could362 Immunity 42, 356–366, February 17, 2015 ª2015 Elsevier Inc.potentiate IL-6 expression by LCs (Haley et al., 2012). It is
important to note that Dectin-1 also cooperates with toll-like
receptor-2 (TLR-2) and TLR-4 to mount pro-inflammtory re-
sponses (Ferwerda et al., 2008; Gantner et al., 2003). In addition
to any possible role for IL-1b, we found that engagement of
Dectin-1 on LCs was required for optimal IL-6 expression. Infec-
tion with a Dectin-1-independent strain induced only low expres-
sion of IL-6 by LCs that failed to induce Th17 cell differentiation.
Addition of exogenous IL-6 was able to rescue the Th17 cell
phenotype. Similarly, patients with Dectin-1 deficiency suffer
from CMC and have defective IL-6 production in response to
C. albicans (Ferwerda et al., 2009). Thus, we have defined a
model in which interaction of LCs with C. albicans yeast results
in a Dectin-1-dependent expression of IL-6 that is required for
Th17 cell differentiation during skin infection.
In the dermis, Dectin-1 is expressed by CD11b+ dDCs but not
CD103+ dDCs. The absence of Dectin-1 on CD103+ dDCs is
consistent with our prior observations that these cells were
required for induction of Th1 cell differentiation (Igya´rto´ et al.,
2011). Despite expressing Dectin-1, CD11b+ dDCs were neither
necessary nor sufficient for optimal induction of Th17 cell re-
sponses to either an epicutaneous or dermal infection with
C. albicans. Importantly, during a dermal infection or an epicuta-
neous infection with Hwp1-Ag, situations in which antigen by-
passes LCs in the epidermis, efficient Th17 cell differentiation
was restored by addition of the exogenous Dectin-1 ligand, cur-
dlan. CD11b+ dDCs have been reported to drive Th2 cell re-
sponses to papain immunization and nippostrongylus infection
Figure 7. Th1 and Th17 Cells Provide Compartmentalized Protection to C. albicans
WT, Il6/, and Batf3/ mice were epicutaneously infected with Eno1-Ag.
(A) The expression of IL-17A and IFN-g by PMA-and-ionomycin-stimulated CD4+ TEa cells isolated from skin draining lymph nodes 4 days after infection is
shown.
(B) The indicated strains of mice were mock infected (white) or skin infected with SC5314. Mice were re-challenged in the skin with SC5314 9 days after
spontaneous clearance of the initial infection. Fungal skin burdens of individual mice is shown as CFU/cm2.
(C) CD4+ T cells were purified from skin draining LN and spleen of naiveWT, SC5314-infected Il6/, or SC5314-infected Batf3/mice 7 days after infection and
adoptively transferred into naiveWT recipients. Recipients were skin infected with SC5314 1 day after transfer and CFUwas assessed at the infected area 2 days
later.
(D) As in (B) except that mice were challenged by i.v. infection with 105 SC5314.
(E) As in (C) except that mice were challenged by i.v. infection with 105 SC5314. Fungal burdens in the kidneys expressed as CFU/g is shown.
Scales represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.(Gao et al., 2013; Kumamoto et al., 2013). Our data suggest that
in addition to Th2 cells, these cells might also have the capacity
to induce Th17 cell differentiation given the appropriate adju-
vant. Indeed, similar IRF4+CD11b+ DCs can produce Th17 cell
responses in other tissues (Persson et al., 2013; Schlitzer
et al., 2013). Thus, the inability of CD11b+ dDCs to induce
Th17 cells is not intrinsic to CD11b+ dDCs but results from the
morphologic change of C. albicans into pseudo-hyphae as it in-
vades into the dermis and probably represents an adaptation of
C. albicans to evade immune responses.
Humans are chronically exposed toC. albicans and circulating
anti-Candida CD4+ Th1 and Th17 cells have been identified (Zie-
linski et al., 2012). The importance of adaptive responses to
C. albicans has been demonstrated by the high prevalence of
mucocutaneous candidiasis in patients with Th17 cell defects
(e.g., hyper IgE syndrome) and some immunodeficiencies (e.g.,
HIV) (McDonald, 2012). Our results as well as the work of others
has found that adaptive responses to C. albicans infection in
mice are also dominated by Th1 and Th17 cells and provide pro-
tection from secondary infection, thus mimicking the response
seen in humans (Conti and Gaffen, 2010; Eyerich et al., 2008;
Huppler et al., 2012; Puel et al., 2011; Zielinski et al., 2012). We
found that Batf3/ mice lacking CD103+ dDCs and Il6/
mice developed either greatly exaggerated or absent Th17 cell
development, respectively, without any alteration in skin innate
responses to C. albicans. Secondary skin infection of mice
with exaggerated Th17 cell expansion resulted in significant
increase in protection compared with mice lacking Th17 cells
that showed no evidence of protection. Mice receiving exoge-nous C. albicans-primed Th17 but not Th1 cells also were
protected from skin infection. Thus, consistent with the well-
documented role of Th17 cells in protection from CMC, Th17
cell expansion provided protection from secondary skin infection
(Eyerich et al., 2008; McDonald, 2012). In addition, the ability of
C. albicans yeast to drive Th17 cell responses and provide pro-
tection argues against the concept that the failure of yeast to
generate Th17 cell is a mechanism that maintains C. albicans
commensalism (Bonifazi et al., 2009; Romani, 2011).
Notably, we found that Th17 cell expansion failed to provide
protection from systemic infection. Rather, enhanced protection
from systemic challenge occurred in Il6/ mice that developed
exaggerated Th1 cells as well as naive recipients of primed
CD4+ T cells isolated from infected Il6/mice. Notably, this pro-
tection developed despite an enhanced susceptibility to primary
disseminated C. albicans that occurs in Il6/ mice (van Encke-
vort et al., 1999). It was also independent of the phenomenon
of reprogrammed monocytes that can provide protection from
systemic infection through an IL-6-dependentmechanism (Quin-
tin et al., 2012). Notably, patients with mutations in STAT1 that
reduce signaling of IFN-g develop increased rates of systemic
infection with C. albicans and other fungi (Puel et al., 2011; Sam-
paio et al., 2013).We speculate that IFN-g or granulocyte-macro-
phage colony-stimulating factor (GM-CSF) derived from Th1 cell
effectors might enhance the anti-Candida responses by promot-
ing increased NK and/or macrophage activity (Ba¨r et al., 2014).
In summary, these data reveal a role for C. albicans
morphology and interaction with a single DC subset for the gen-
eration of Th17 cell responses. In addition, the tissue-selectiveImmunity 42, 356–366, February 17, 2015 ª2015 Elsevier Inc. 363
protection afforded by Th17 and Th1 cell effectors reveals
a compartmentalization of Th cell function that suggests a
rational basis for the development of Th-cell-phenotype-specific
C. albicans vaccines.
EXPERIMENTAL PROCEDURES
Mice
Mgl2eGFP-DTR/wt (referred to asMgl2-DTR), human Langerin-DTA (LC), human
Langerin-DTA 3 Batf3/ (referred to as LC 3 Batf3/), huLangerin-DTR,
muLangerin-eGFP, human Langerin-creERT2, YFP, Tgfb1f, Tgfbr2f, and
Clec7a/ mice have been previously described (Bobr et al., 2012; Kaplan
et al., 2005; Kissenpfennig et al., 2005; Kumamoto et al., 2013; Taylor et al.,
2007; Welty et al., 2013). Il1b/ and Il6/ mice were purchased from The
Jackson Laboratory. C57BL/6 and B6-Ly5.2/Cr were purchased from the Na-
tional Cancer Institute or Charles River laboratories. CD90.1 Rag1/ CD4+
TEa TCR-transgenic mice that recognize Ea50-66 in I-A
b on C57BL/6 back-
grounds were also used (Grubin et al., 1997). All experiments were performed
with 6- to 12-week-old and sex-matchedmice. Mice were housed in microiso-
lator cages and fed irradiated food and acidified water. The University of
Minnesota institutional care and use committee approved all mouse protocols.
Generation and Testing of Bone Marrow Chimeric Mice
6-week-old cytokine-deficient, wild-type C57BL/6 or Ly5.2 congenically
marked mice were irradiated with X-ray irradiator as previously described.
The mice received two split doses at 500 cGy each. The following day, 5 3
106 bone marrow cells isolated from specified mice were injected intrave-
nously. Mice were rested for at least 6 weeks prior to experiments. The effi-
ciency of chimerism was determined by flow cytometry of congenic markers
on PBMC, lymph node, and epidermis.
DC Depletion with Diphtheria Toxin
Mgl2-DTR and huLangerin-DTRmice were i.p. injected with 1mg of diphtheria
toxin (List Biological Laboratories) 2 days before infection, as previously
described (Bobr et al., 2010; Igya´rto´ et al., 2011).
Tamoxifen Treatment
Tamoxifen (Sigma Aldrich) was dissolved in corn oil (Sigma Aldrich) and 10%
ethanol andwas administered 5 consecutive days by i.p. injection at 0.05mg/g
of mouse weight.
Antibodies
Fluorochrome-conjugated antibodies to CD4 (GK1.5), CD11b (M1/70), CD11c
(N418), CD45.1 (A20), CD45.2 (104), CD90.1 (OX-7), CD103 (2E7), I-A/I-E
(M5/114.15.2), Dectin-1 (RH1), IFN-g (XMG1.2), IL-10 (JES5-16E3), and
IL-17A (TC11-18H10.1) were purchased from BioLegend. Anti-mouse Lan-
gerin (L31), IL-17F (18F10), IL-22 (1H8PWSR), and Foxp3 (FJK-16S) were
acquired from eBioscience.
Adoptive T Cell Transfer
T cells were adoptively transferred as previously described (Igya´rto´ et al.,
2011). In brief, skin draining lymph nodes, spleen, and mesenteric lymph
node of TEa mice were disrupted through a cell strainer, washed with sterile
HBSS, and labeled with CFSE (Invitrogen) in accordance with the manufac-
turer’s instructions. The cells after two washes were resuspended in sterile
PBS at a concentration of 1 3 106 cell/ml and 300 ml (3 3 105 cells) were
injected intravenously into recipients.
In certain experiments, single-cell suspension from secondary lymphoid
organs from either naive wild-type or skin-infected Il6- or Batf3-deficient
mice were obtained. CD4+ T cells were magnetically isolated at >95% purity
(STEMCELL Technologies) according to manufacturer’s directions. A total of
5 3 106 million purified CD4+ T cells were transferred into naive hosts in
300 ml PBS.
Flow Cytometry
Single-cell suspensions of epidermal cells were obtained as previously defined
(Kaplan et al., 2005). In brief, skin from ear or trunk were obtained and364 Immunity 42, 356–366, February 17, 2015 ª2015 Elsevier Inc.incubated for 2 hr at 37C in 0.3% trypsin (Sigma-Aldrich) in 150 mM NaCl,
0.5 mM KCl, 0.5 mM glucose. The epidermis was physically separated from
the dermis. Dermal cells were obtained from whole flank skin. Samples were
minced and incubated for 2 hr at 37C in collagenase XI (4,830 U/ml, Sigma),
hyaluronidase (260 U/ml, Sigma), DNase (0.1 mg/ml, ICN), 10 mM HEPES
(Sigma) in RPMI (Invitrogen). The resulting cells were filtered through a
40 mm filter. Lymph node (axillary, brachial, and inguinal) and spleen cells
were incubated in 400 and 150 U/ml Collagenase D for preparation of dendritic
cells or smashed through a filter for lymphocytes (Roche Applied Science),
respectively, for 90 min prior to erythroid cell lysis in ACK buffer (Biowhittaker).
Single-cell suspensions were pretreated for 10 min at 4C with 2.4G2 except
when anti-Rat secondaries were used, in which case cells were blocked
with mouse Ig (Sigma). For evaluating cytokine expression, cells were incu-
bated for 5 hr in complete IDMEM supplemented with PMA (50 ng/ml) and
ionomycin (1.5 mM; Sigma-Aldrich), with GolgiStop (BD PharMingen) added
for the final 4 hr. The intracellular cytokine staining was performed with BD
Bioscience Cytofix/Cytoperm kit (BD Biosciences) in accordance with the
manufacturer’s instructions. Samples were analyzed on LSR-II flow cytome-
ters (BD Biosciences). Data were analyzed with FlowJo software (TreeStar).
Detection of 2W1S-specific CD4+ T cells was performed as published with
an I-Ab-2W1S tetramer (a kind gift of M. Jenkins) after ex vivo stimulation of
secondary organs as previously described (Moon et al., 2007).
DC Sorting by Flow Cytometry and qPCR
Single-cell suspensions of LN cells were enriched by CD11c MACS positive
selection (Miltenyi Biotec). LCs were sorted with a FACSAria cell sorter based
as GFP+, MHCII+, CD11c+, CD11b+, CD103CD8. RNA was isolated with
an RNeasy Mini Kit (QIAGEN) and quantified from Nanodrop readings
(NanoDrop). cDNA was generated with a High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems). TaqMan Gene Expression Master Mix
and TaqMan Gene Expression Assays for IL-1, IL-6, and IL-12p40 was used.
ABI Prism 7900HT (Applied Biosystems) were used to complete the qPCR.
All kits were completed according the manufacturer’s instructions. All Ct
values were normalized to HPRT expression and are shown as 2DCt to naive.
Candida albicans Strains
RecombinantC. albicans used in this study was derived from SC5314 and was
designed as previously described (Fonzi and Irwin, 1993; Igya´rto´ et al., 2011).
They were grown in rich medium at 30C (YPAD) or in synthetic complete me-
dium. Escherichia coli strain XLI-blue (Stratagene), growth conditions, DNA
manipulations, and primer design and synthesis were essentially as described
previously. Transformants were selected on YPAD medium containing
400 mg/ml nourseothricin and were screened by PCR with oligonucleotide
primers listed (Figure S2C). In brief, strain Hwp1-eGFP-Ag was constructed
as follows: plasmid pMG2268was PCRwith Primers 875 and 5266. PCR prod-
uct was transformed into wild-type strain SC5314 by standard methods
(Igya´rto´ et al., 2011). Transformants were selected on YPAD medium contain-
ing 400 mg/ml nourseothricin. Integration at the HWP1 locus was confirmed
with two primers (877/3290) confirming integration of GFP-antigen at HWP1.
C. albicans strains s20175.016, yeast locked strain (JKC19), and filament
locked strain (BCa2-9) were kindly provided by Dr. Neal Gow (University of
Aberdeen) (Braun and Johnson, 1997; Liu et al., 1994; Maccallum, 2012;
Marakalala et al., 2013). Growth of fungi occurred after inoculation of a colony
at 30C in YPAD overnight and, the next day, diluted 1:10 and cultured either at
30C in YPAD until OD600 reached 1.5 for yeast morphology or at 37C in RPMI
with 10% FBS for 3 hr for filamentous forms.
Infection Models
The skin infection was performed as described (Igya´rto´ et al., 2011). In brief,
mice were first anesthetized with a mixture of ketamine and xylazine (100/
10 mg/kg body weight), shaved on the back with electric clipper, and chemi-
cally depilated with Nair hair remover (Church & Dwight) per the manufac-
turer’s instructions. The stratum corneum was removed with 15 strokes with
220 grit sandpaper (3M). After washing with sterile PBS, 2 3 108 C. albicans
in 50 ml of sterile PBS was applied to the skin. In some experiments, same
dose of C. albicans or 50 mg curdlan was injected intradermally spaced over
10 sites on the back. Where indicated, recombinant murine IL-6 (BioLegend)
was injected into 4 different sites in the dorsum of the mice intradermally at
a total dose of 1 mg per mice. i.v. infections with Eno1-Ag and Hwp1-Ag for
assessment of T cell expansion were performed at 3 3 105 CFU in PBS.
In re-challenge experiments, previously mock or epicutaneously infected
mice were challenged with 1 3 106 CFU C. albicans by being intradermally
injected into a single site or by 1 3 105 CFU intravenously. Skin and kidneys
were harvest from mice 3 days later and homogenized and serially diluted
onto YPAD plates and incubated at 30C for 24–48 hr to assess the number
of colony-forming units.
LC Targeting with Anti-huLangerin
Anti-human-Langerin antibodies (2G3) conjugated to antigen were generated
and administered as previously described (Igya´rto´ et al., 2011). In brief,WT and
huLangerin-DTR mice were immunized by intraperitoneal injection of 1.0 mg of
2G3-Ea in 100 ml of sterile PBS. Six hours later, the mice were infected with the
pathogen strains noted as above.
Histology
Immunofluorescence on ear epidermis was performed as previously
described (Kaplan et al., 2005). Images were captured with a microscope
(DM5500; Leica) with digital system and LAS AF software (v.1.5.1). Periodic
Acid-Schiff (PAS) staining for fungal invasionwas performed 2 days after infec-
tion with SC5314 on formaldehyde-fixed frozen sections with commercial PAS
staining kit (Sigma-Aldrich).
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